Hudson Bay Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.6M Buy
386,523
+84,573
+28% +$4.51M 0.07% 136
2025
Q1
$12.2M Buy
301,950
+126,950
+73% +$5.14M 0.04% 210
2024
Q4
$4.87M Buy
175,000
+20,000
+13% +$556K 0.02% 365
2024
Q3
$4.45M Buy
+155,000
New +$4.45M 0.02% 318